BNTC icon

Benitec Biopharma
BNTC

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $1.23M invested in Benitec Biopharma in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$294K
2
+$30K
3
+$20.6K

Top Sellers

1
-$1.18M
2
-$84K
3
-$40K
4
UBS Group
UBS Group
Switzerland
-$4.38K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$647K
2
$294K
3
$141K
4
$84K
5
$32K
6
$30K
7
$5K
8
–